CIK 0001160308
- Non-accelerated filer
- Smaller reporting company
Savara Inc
Sign in to watch- Ticker
- SVRA
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 841318182
- Phone
- +51 285113796
- Business address
- 6836 BEE CAVE ROAD, BUILDING 3, SUITE 201, AUSTIN, TX, 78746
- Former names
- Mast Therapeutics, Inc., ADVENTRX PHARMACEUTICALS INC, BIOKEYS PHARMACEUTICALS INC
- 4 Open-market buy Director bought 200,000 shares at an average $1.08 ($215,393)
- 4 Open-market buy CHIEF EXECUTIVE OFFICER bought 22,150 shares at an average $1.10 ($24,390)
- 4 Open-market buy Director bought 137,052 shares at an average $1.29 ($176,382)
- 4 Exercise or conversion Director acquired 2,288 shares (option exercise)
- 4 Open-market buy Director bought 97,290 shares at an average $1.18 ($115,181)
- 4 Open-market buy CHIEF EXECUTIVE OFFICER bought 26,900 shares at an average $1.18 ($31,866)
- 4 Open-market buy CHIEF EXECUTIVE OFFICER bought 10,000 shares at $1.63 ($16,298)
- 4 Open-market buy Director bought 5,003 shares at $1.58 ($7,905)
- 4 Open-market buy Director bought 50,000 shares at $1.62 ($81,100)
- 4 Open-market sale CHIEF MEDICAL OFFICER sold 50,000 shares at $1.56 ($77,870)
- 4 Open-market buy CHIEF EXECUTIVE OFFICER bought 27,400 shares at $1.82 ($49,871)
- 4 Open-market buy CHIEF EXECUTIVE OFFICER bought 24,100 shares at $2.07 ($49,938)
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
Page 7 of 22 · 436 filings